WHO urges 47 African countries to implement antimicrobial resistance plans
By the AFREEQUE newsroom, based on Leadership
The WHO is calling on 47 African countries to turn their national plans into funded and measurable action, according to its Regional Director, Mohamed Janabi. On the occasion of World Antimicrobial Resistance Awareness Week, he recalls that antimicrobial resistance was associated with 4.7 million deaths worldwide in 2021, with sub-Saharan Africa recording the highest rates.
The World Health Organization (WHO) is calling on the 47 countries in its African Region to implement their national strategies against antimicrobial resistance. Its Regional Director, Mohamed Janabi, made the appeal on Wednesday 18 November, on the occasion of World Antimicrobial Resistance Awareness Week, held from 18 to 24 November 2026.
In 2021, bacterial resistance to treatments was associated with approximately 4.7 million deaths worldwide. Sub-Saharan Africa has the highest mortality rates linked to this phenomenon, according to Mohamed Janabi. Antimicrobial resistance occurs when bacteria, viruses, fungi or parasites no longer respond to the medicines used to combat them. It makes infections particularly difficult to treat and threatens the progress made in surgery, cancer care and organ transplants.
The WHO Africa official identified several aggravating factors: inappropriate use of medicines in humans and animals, shortcomings in infection prevention, lack of access to water and sanitation, and poor waste management. He advocates a coordinated approach across the human, animal, plant and environmental health sectors.
The 47 African countries concerned participate in the WHO’s global antimicrobial resistance surveillance system. Among them, 44 have testing capabilities to assess the susceptibility of major bacteria to antibiotics. Thirty-six have also adopted the WHO classification, which divides these medicines into three groups: access, watch and reserve. This classification is intended in particular to promote responsible prescribing and support the global target of reserving at least 70% of antibiotics used in human healthcare for the access group by 2030.
Mohamed Janabi’s appeal comes two days after the publication of WHO projections on the consequences of antimicrobial resistance, which forecast 39 million deaths linked to the phenomenon worldwide.





